Gefapixant
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
Molecular Identity
Gefapixant
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
PubChem CID: 24764487
2D Structure
Properties
C14H19N5O4S
Molecular Formula
353.40
Molecular Weight
g/mol
353.1158
Exact Mass
Da
0.7
XLogP
Drug-like (Lipinski: < 5)
165
TPSA
May have limited oral absorption
3
H-Bond Donors
9
H-Bond Acceptors
512
Complexity
SMILES
Canonical SMILES
SMILES: CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OCIsomeric SMILES
SMILES: CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OCSynonyms(20)
Gefapixant1015787-98-0AF-219Ro-4926219RO4926219RG-16465-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamideBenzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-6K6L7E3F1LR-16465-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamideDTXSID401337212Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-gefapixantum5-((2,4-diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Gefapixant
Loading drug network...